Jeil Pharma Holdings Inc (KRX:002620)
6,360.00
-170.00 (-2.60%)
At close: Jun 24, 2026
Jeil Pharma Holdings Market Cap
Jeil Pharma Holdings has a market cap or net worth of 100.24 billion as of June 24, 2026. Its market cap has decreased by -19.28% in one year.
Market Cap
100.24B
Enterprise Value
341.26B
Revenue
625.97B
Ranking
n/a
PE Ratio
7.46
Stock Price
6,360.00
Market Cap Chart
Since August 30, 1995, Jeil Pharma Holdings's market cap has increased from 26.30B to 100.24B, an increase of 281.21%. That is a compound annual growth rate of 4.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 100.24B | -18.78% |
| Dec 30, 2025 | 123.42B | 2.81% |
| Dec 30, 2024 | 120.05B | -33.56% |
| Dec 28, 2023 | 180.68B | -23.57% |
| Dec 29, 2022 | 236.41B | -3.75% |
| Dec 30, 2021 | 245.62B | -24.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Daihan Pharmaceutical | 149.94B |
| CMG Pharmaceutical | 148.88B |
| Samil Pharmaceutical Co.,Ltd | 146.70B |
| Ilyang Pharmaceutical Co.,Ltd | 143.22B |
| Dongwha Pharm.Co.,Ltd | 140.81B |
| Ilsung Is | 134.78B |
| SAMSUNG PHARM. Co., LTD. | 134.59B |
| AptaBio Therapeutics | 126.42B |